MRP1 Gene Expression Level Regulates the Death and Differentiation Response of Neuroblastoma Cells

Overview

Journal Br J Cancer

Specialty Oncology

Date 2001 Nov 27

PMID 11720446

Citations 15

Authors

A E Peaston

M Gardaneh

A V Franco

J E Hocker

K M Murphy

M L Farnsworth

D R Catchpoole

M Haber

M D Norris

R B Lock

G M Marshall

Affiliations

Soon will be listed here.

Abstract

We have previously reported a strong correlation between poor prognosis in childhood neuroblastoma (NB) patients and high-level expression of the transmembrane efflux pump, Multidrug Resistance-associated Protein (MRP1), in NB tumour tissue. In this study, we inhibited the endogenous expression of MRP1 in 2 different NB tumour cell lines by stably transfecting an MRP1 antisense expression vector (MRP-AS). Compared with control cells, MRP-AS transfectant cells demonstrated a higher proportion of dead and morphologically apoptotic cells, spontaneous neuritogenesis, and, increased synaptophysin and neurofilament expression. Bcl-2 protein expression was markedly reduced in MRP-AS cells compared to controls. Conversely, we found that the same NB tumour cell line overexpressing the full-length MRP1 cDNA in sense orientation (MRP-S) demonstrated resistance to the neuritogenic effect of the differentiating agent, all-trans-retinoic acid. Taken together, the results suggest that the level of MRP1 expression in NB tumour cells may influence the capacity of NB cells for spontaneous regression in vivo through cell differentiation and death.

Citing Articles

PIM Kinase Inhibition Sensitizes Neuroblastoma to Doxorubicin.

Julson J, Quinn C, Nazam N, Bownes L, Stewart J, Beierle E J Pediatr Surg. 2024; 59(7):1334-1341.

PMID: 38570263 PMC: 11164644. DOI: 10.1016/j.jpedsurg.2024.03.014.

ABCC6 Knockdown Fuels Cell Proliferation by Regulating PPARα in Hepatocellular Carcinoma.

Zhao Z, Zhao Z, Wang J, Zhang H, Xi Z, Xia Q Front Oncol. 2022; 12:840287.

PMID: 35280774 PMC: 8907651. DOI: 10.3389/fonc.2022.840287.

Therapeutically targeting oncogenic CRCs facilitates induced differentiation of NB by RA and the BET bromodomain inhibitor.

Alleboina S, Aljouda N, Miller M, Freeman K Mol Ther Oncolytics. 2021; 23:181-191.

PMID: 34729395 PMC: 8526497. DOI: 10.1016/j.omto.2021.09.004.

The Combination of the M2 Muscarinic Receptor Agonist and Chemotherapy Affects Drug Resistance in Neuroblastoma Cells.

Luciano A, Perciballi E, Fiore M, Del Bufalo D, Tata A Int J Mol Sci. 2020; 21(22).

PMID: 33182656 PMC: 7697391. DOI: 10.3390/ijms21228433.

Transport-Mediated Oxaliplatin Resistance Associated with Endogenous Overexpression of MRP2 in Caco-2 and PANC-1 Cells.

Biswas R, Bugde P, He J, Merien F, Lu J, Liu D Cancers (Basel). 2019; 11(9).

PMID: 31500349 PMC: 6770320. DOI: 10.3390/cancers11091330.

References

Chomczynski P, Sacchi N . Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162(1):156-9. DOI: 10.1006/abio.1987.9999. View

Beckwith J, PERRIN E . IN SITU NEUROBLASTOMAS: A CONTRIBUTION TO THE NATURAL HISTORY OF NEURAL CREST TUMORS. Am J Pathol. 1963; 43:1089-104. PMC: 1949785. View

Cole S, Bhardwaj G, Gerlach J, MACKIE J, Grant C, Almquist K . Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science. 1992; 258(5088):1650-4. DOI: 10.1126/science.1360704. View

Grant C, Valdimarsson G, Hipfner D, Almquist K, Cole S, Deeley R . Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res. 1994; 54(2):357-61. View

Bordow S, Haber M, Madafiglio J, Cheung B, Marshall G, Norris M . Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma. Cancer Res. 1994; 54(19):5036-40. View

Cole S, Sparks K, Fraser K, Loe D, Grant C, WILSON G . Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res. 1994; 54(22):5902-10. View

Haber M, Madafiglio J, Bordow S, Gilbert J, Cheung B, Marshall G . Expression of retinoic acid-responsive genes in primary neuroblastomas. Prog Clin Biol Res. 1994; 385:245-51. View

Hoehner J, Hedborg F, Wiklund H, Olsen L, Pahlman S . Cellular death in neuroblastoma: in situ correlation of apoptosis and bcl-2 expression. Int J Cancer. 1995; 62(1):19-24. DOI: 10.1002/ijc.2910620106. View

Marshall G, Cheung B, Stacey K, Camacho M, Simpson A, Kwan E . Increased retinoic acid receptor gamma expression suppresses the malignant phenotype and alters the differentiation potential of human neuroblastoma cells. Oncogene. 1995; 11(3):485-91. View

10.

Norris M, Bordow S, Marshall G, Haber P, Cohn S, Haber M . Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma. N Engl J Med. 1996; 334(4):231-8. DOI: 10.1056/NEJM199601253340405. View

11.

Lock R, Stribinskiene L . Dual modes of death induced by etoposide in human epithelial tumor cells allow Bcl-2 to inhibit apoptosis without affecting clonogenic survival. Cancer Res. 1996; 56(17):4006-12. View

12.

Woods W, Tuchman M, Robison L, Bernstein M, Leclerc J, Brisson L . A population-based study of the usefulness of screening for neuroblastoma. Lancet. 1996; 348(9043):1682-7. DOI: 10.1016/S0140-6736(96)06020-5. View

13.

Davies A . Neurotrophin switching: where does it stand?. Curr Opin Neurobiol. 1997; 7(1):110-8. DOI: 10.1016/s0959-4388(97)80128-6. View

14.

Kroemer G . The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med. 1997; 3(6):614-20. DOI: 10.1038/nm0697-614. View

15.

Robinson L, Roberts W, Ling T, Lamming D, Sternberg S, Roepe P . Human MDR 1 protein overexpression delays the apoptotic cascade in Chinese hamster ovary fibroblasts. Biochemistry. 1997; 36(37):11169-78. DOI: 10.1021/bi9627830. View

16.

Wijnholds J, Evers R, van Leusden M, Mol C, Zaman G, Mayer U . Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nat Med. 1997; 3(11):1275-9. DOI: 10.1038/nm1197-1275. View

17.

Lorico A, Rappa G, Finch R, Yang D, Flavell R, Sartorelli A . Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione. Cancer Res. 1997; 57(23):5238-42. View

18.

Deeley R, Cole S . Function, evolution and structure of multidrug resistance protein (MRP). Semin Cancer Biol. 1997; 8(3):193-204. DOI: 10.1006/scbi.1997.0070. View

19.

Evans A, GERSON J, SCHNAUFER L . Spontaneous regression of neuroblastoma. Natl Cancer Inst Monogr. 1976; 44:49-54. View

20.

Shimada H, CHATTEN J, NEWTON Jr W, Sachs N, Hamoudi A, Chiba T . Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst. 1984; 73(2):405-16. DOI: 10.1093/jnci/73.2.405. View